Jacqueline Shea is President, Chief Executive Officer and Director of Inovio Pharmaceuticals, Inc. (INO). The company reported total compensation of $1,587,155 for fiscal year 2025.
| Salary | $728,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $346,101 |
| Option awards | $351,955 |
| Non-equity incentive plan | $144,144 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $16,955 |
| Total | $1,587,155 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Inovio Pharmaceuticals, Inc. filed April 7, 2026, accession 0001055726-26-000011.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Director | $728,000 | $0 | $346,101 | $351,955 | $144,144 | $0 | $16,955 | $1,587,155 |
| FY2024 | President, Chief Executive Officer and Director | $728,000 | $0 | $490,819 | $475,977 | $340,704 | $0 | $15,169 | $2,050,669 |
Totals as disclosed in each year's own compensation disclosure for Inovio Pharmaceuticals, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jacqueline Shea this page | President, Chief Executive Officer and Director | $1,587,155 |
| Michael Sumner | Chief Medical Officer and Head of Development | $910,636 |
| Peter Kies | Chief Financial Officer | $833,684 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Inovio Pharmaceuticals, Inc. compensation brief.
Jacqueline Shea's compensation sits inside Inovio Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.